622 related articles for article (PubMed ID: 12782669)
21. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
Wan M; Godson C; Guiry PJ; Agerberth B; Haeggström JZ
FASEB J; 2011 May; 25(5):1697-705. PubMed ID: 21307335
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells.
Redfern RL; Reins RY; McDermott AM
Exp Eye Res; 2011 Mar; 92(3):209-20. PubMed ID: 21195713
[TBL] [Abstract][Full Text] [Related]
23. The human cathelicidin LL-37--A pore-forming antibacterial peptide and host-cell modulator.
Xhindoli D; Pacor S; Benincasa M; Scocchi M; Gennaro R; Tossi A
Biochim Biophys Acta; 2016 Mar; 1858(3):546-66. PubMed ID: 26556394
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37.
Carretero M; Escámez MJ; García M; Duarte B; Holguín A; Retamosa L; Jorcano JL; Río MD; Larcher F
J Invest Dermatol; 2008 Jan; 128(1):223-36. PubMed ID: 17805349
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human macrophages.
Wan M; van der Does AM; Tang X; Lindbom L; Agerberth B; Haeggström JZ
J Leukoc Biol; 2014 Jun; 95(6):971-81. PubMed ID: 24550523
[TBL] [Abstract][Full Text] [Related]
26. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells.
Lau YE; Rozek A; Scott MG; Goosney DL; Davidson DJ; Hancock RE
Infect Immun; 2005 Jan; 73(1):583-91. PubMed ID: 15618198
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the antimicrobial peptide LL-37 in human atherosclerosis.
Edfeldt K; Agerberth B; Rottenberg ME; Gudmundsson GH; Wang XB; Mandal K; Xu Q; Yan ZQ
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1551-7. PubMed ID: 16645154
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary defense and the human cathelicidin hCAP-18/LL-37.
Fahy RJ; Wewers MD
Immunol Res; 2005; 31(2):75-89. PubMed ID: 15778507
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface.
Huang LC; Petkova TD; Reins RY; Proske RJ; McDermott AM
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2369-80. PubMed ID: 16723446
[TBL] [Abstract][Full Text] [Related]
30. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways.
Yu J; Mookherjee N; Wee K; Bowdish DM; Pistolic J; Li Y; Rehaume L; Hancock RE
J Immunol; 2007 Dec; 179(11):7684-91. PubMed ID: 18025214
[TBL] [Abstract][Full Text] [Related]
31. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.
Barlow PG; Li Y; Wilkinson TS; Bowdish DM; Lau YE; Cosseau C; Haslett C; Simpson AJ; Hancock RE; Davidson DJ
J Leukoc Biol; 2006 Sep; 80(3):509-20. PubMed ID: 16793910
[TBL] [Abstract][Full Text] [Related]
32. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections.
Méndez-Samperio P
Peptides; 2010 Sep; 31(9):1791-8. PubMed ID: 20600427
[TBL] [Abstract][Full Text] [Related]
33. Recombinant adeno-associated virus-based gene transfer of cathelicidin induces therapeutic neovascularization preferentially via potent collateral growth.
Pinkenburg O; Pfosser A; Hinkel R; Böttcher M; Dinges C; Lebherz C; Sultana S; Enssle J; El-Aouni C; Büning H; Boekstegers P; Bals R; Kupatt C
Hum Gene Ther; 2009 Feb; 20(2):159-67. PubMed ID: 20377367
[TBL] [Abstract][Full Text] [Related]
34. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis.
Sandgren S; Wittrup A; Cheng F; Jönsson M; Eklund E; Busch S; Belting M
J Biol Chem; 2004 Apr; 279(17):17951-6. PubMed ID: 14963039
[TBL] [Abstract][Full Text] [Related]
35. Anti-adenoviral effects of human cationic antimicrobial protein-18/LL-37, an antimicrobial peptide, by quantitative polymerase chain reaction.
Uchio E; Inoue H; Kadonosono K
Korean J Ophthalmol; 2013 Jun; 27(3):199-203. PubMed ID: 23730113
[TBL] [Abstract][Full Text] [Related]
36. Porphyromonas gingivalis-induced IL-33 down-regulates hCAP-18/LL-37 production in human gingival epithelial cells.
Tada H; Shimizu T; Matsushita K; Takada H
Biomed Res; 2017; 38(3):167-173. PubMed ID: 28637951
[TBL] [Abstract][Full Text] [Related]
37. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide.
Bals R; Weiner DJ; Moscioni AD; Meegalla RL; Wilson JM
Infect Immun; 1999 Nov; 67(11):6084-9. PubMed ID: 10531270
[TBL] [Abstract][Full Text] [Related]
38. Endogenous antimicrobial peptide LL-37 induces human vasodilatation.
Berkestedt I; Nelson A; Bodelsson M
Br J Anaesth; 2008 Jun; 100(6):803-9. PubMed ID: 18397922
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.
Zaiou M; Nizet V; Gallo RL
J Invest Dermatol; 2003 May; 120(5):810-6. PubMed ID: 12713586
[TBL] [Abstract][Full Text] [Related]
40. The role of the multifunctional peptide LL-37 in host defense.
Kai-Larsen Y; Agerberth B
Front Biosci; 2008 May; 13():3760-7. PubMed ID: 18508470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
